Latest stories on AVTX
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire52 · neutralproduct/pr
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Business Insider52 · neutralproduct/pr
Oppenheimer cuts Avalo Therapeutics price target on trial concerns
Investing.com Analyst Ratings34 · bearishanalyst
Avalo Therapeutics price target lowered to $16 from $35 at Oppenheimer
The Fly28 · bearishanalyst
Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3
Seeking Alpha64 · neutralanalyst
Avalo Therapeutics price target lowered to $22 from $34 at Wedbush
The Fly34 · bearishanalyst
Avalo Therapeutics downgraded to Neutral at Guggenheim after AbbVie data
The Fly38 · neutralanalyst
Avalo Therapeutics price target lowered to $10 from $58 at BTIG
The Fly22 · bearishanalyst
Guggenheim downgrades Avalo Therapeutics stock rating on IL-1 data
Investing.com Analyst Ratings34 · bearishanalyst
Avalo Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
The Fly34 · bearishanalyst
Avalo Therapeutics downgraded to Neutral from Buy at Guggenheim
The Fly34 · bearishanalyst
Avalo Therapeutics trading resumes
The Fly50 · neutralgeneral
Avalo Therapeutics trading halted, volatility trading pause
The Fly42 · neutralgeneral
H.C. Wainwright reiterates Avalo Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
GlobeNewswire63 · neutralproduct/pr
Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress
Business Insider56 · neutralproduct/pr
Cantor Fitzgerald reiterates Avalo Therapeutics stock rating
Investing.com Analyst Ratings50 · neutralanalyst
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Avalo Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Avalo Therapeutics price target lowered to $48 from $50 at Guggenheim
The Fly42 · neutralanalyst
Avalo Therapeutics price target lowered to $30 from $35 at H.C. Wainwright
The Fly34 · bearishanalyst